Trial Outcomes & Findings for Performance of Aspheric Hydrogel Lenses After a Refit With Sphere Silicone Hydrogel Lenses for 4 Weeks (NCT NCT03835078)

NCT ID: NCT03835078

Last Updated: 2020-06-11

Results Overview

Lens centration assessment using 3-point scale (1=optimal centration, 2=decentration acceptable, 3=decentration unacceptable).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

42 participants

Primary outcome timeframe

Baseline

Results posted on

2020-06-11

Participant Flow

42 subjects were enrolled but three subjects did not satisfy the minimum number of days / hours of wear during the study and excluded from all the analysis.

Participant milestones

Participant milestones
Measure
Methalfilcon A Contact Lenses / Fanfilcon A Contact Lenses
All subjects will first wear methafilcon A contact lenses for four (4) weeks of daily wear, then be refitted with fanfilcon A toric contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses fanfilcon A contact lenses: Bilateral daily wear of fanfilcon A contact lenses
Overall Study
STARTED
39
Overall Study
COMPLETED
39
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Overall Study
n=39 Participants
Total Participants
Age, Categorical
<=18 years
0 Participants
n=39 Participants
Age, Categorical
Between 18 and 65 years
39 Participants
n=39 Participants
Age, Categorical
>=65 years
0 Participants
n=39 Participants
Age, Continuous
25.3 years
STANDARD_DEVIATION 6.7 • n=39 Participants
Sex: Female, Male
Female
24 Participants
n=39 Participants
Sex: Female, Male
Male
15 Participants
n=39 Participants
Region of Enrollment
Mexico
39 participants
n=39 Participants

PRIMARY outcome

Timeframe: Baseline

Lens centration assessment using 3-point scale (1=optimal centration, 2=decentration acceptable, 3=decentration unacceptable).

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Percentage of Participants With Lens Centration Assessment by the Investigator - Methafilcon A Contact Lenses
Optimal Centration
100 percentage of participants
Percentage of Participants With Lens Centration Assessment by the Investigator - Methafilcon A Contact Lenses
Decentration Acceptable
0 percentage of participants
Percentage of Participants With Lens Centration Assessment by the Investigator - Methafilcon A Contact Lenses
Decentartion Unacceptable
0 percentage of participants

PRIMARY outcome

Timeframe: 4 weeks

Lens centration assessment using 3-point scale (1=optimal centration, 2=decentration acceptable, 3=decentration unacceptable).

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Percentage of Participants With Lens Centration Assessment by the Investigator - Methafilcon A Contact Lenses
Decentration Acceptable
0 percentage of participants
Percentage of Participants With Lens Centration Assessment by the Investigator - Methafilcon A Contact Lenses
Decentration Unacceptable
0 percentage of participants
Percentage of Participants With Lens Centration Assessment by the Investigator - Methafilcon A Contact Lenses
Optimal Centration
100 percentage of participants

PRIMARY outcome

Timeframe: Baseline

Lens centration assessment using 3-point scale (1=optimal centration, 2=decentration acceptable, 3=decentration unacceptable).

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Percentage of Participants With Lens Centration Assessment by the Investigator - Fanfilcon A Contact Lenses
Optimal Centration
100 percentage of participants
Percentage of Participants With Lens Centration Assessment by the Investigator - Fanfilcon A Contact Lenses
Decentration Acceptable
0 percentage of participants
Percentage of Participants With Lens Centration Assessment by the Investigator - Fanfilcon A Contact Lenses
Decentration Unacceptable
0 percentage of participants

PRIMARY outcome

Timeframe: 2 weeks

Lens centration assessment using 3-point scale (1=optimal centration, 2=decentration acceptable, 3=decentration unacceptable).

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Percentage of Participants With Lens Centration Assessment by the Investigator - Fanfilcon A Contact Lenses
Optimal Centration
100 percentage of participants
Percentage of Participants With Lens Centration Assessment by the Investigator - Fanfilcon A Contact Lenses
Decentration Acceptable
0 percentage of participants
Percentage of Participants With Lens Centration Assessment by the Investigator - Fanfilcon A Contact Lenses
Decentration Unacceptable
0 percentage of participants

PRIMARY outcome

Timeframe: 4 weeks

Lens centration assessment using 3-point scale (1=optimal centration, 2=decentration acceptable, 3=decentration unacceptable).

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Percentage of Participants With Lens Centration Assessment by the Investigator - Fanfilcon A Contact Lenses
Optimal Centration
100 percentage of participants
Percentage of Participants With Lens Centration Assessment by the Investigator - Fanfilcon A Contact Lenses
Decentartion Acceptable
0 percentage of participants
Percentage of Participants With Lens Centration Assessment by the Investigator - Fanfilcon A Contact Lenses
Decentration Unacceptable
0 percentage of participants

PRIMARY outcome

Timeframe: Baseline

Corneal coverage is collected on a YES/NO response. Yes - lens covers the cornea, No - lens does not cover the cornea

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Percentage of Participants With Corneal Coverage Assessment by the Investigator - Methafilcon A Contact Lenses
Yes
97.4 percentage of participants
Percentage of Participants With Corneal Coverage Assessment by the Investigator - Methafilcon A Contact Lenses
No
2.6 percentage of participants

PRIMARY outcome

Timeframe: 4 weeks

Corneal coverage is collected on a YES/NO response. Yes - lens covers the cornea, No - lens does not cover the cornea

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Percentage of Participants With Corneal Coverage Assessment by the Investigator - Methafilcon A Contact Lenses
Yes
100 percentage of participants
Percentage of Participants With Corneal Coverage Assessment by the Investigator - Methafilcon A Contact Lenses
No
0 percentage of participants

PRIMARY outcome

Timeframe: Baseline

Corneal coverage is collected on a YES/NO response. Yes - lens covers the cornea, No - lens does not cover the cornea

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Percentage of Participants With Corneal Coverage Assessment by the Investigator - Fanfilcon A Contact Lenses
Yes
100 percentage of participants
Percentage of Participants With Corneal Coverage Assessment by the Investigator - Fanfilcon A Contact Lenses
No
0 percentage of participants

PRIMARY outcome

Timeframe: 2 weeks

Corneal coverage is collected on a YES/NO response. Yes - lens covers the cornea, No - lens does not cover the cornea

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Percentage of Participants With Corneal Coverage Assessment by the Investigator - Fanfilcon A Contact Lenses
Yes
100 percentage of participants
Percentage of Participants With Corneal Coverage Assessment by the Investigator - Fanfilcon A Contact Lenses
No
0 percentage of participants

PRIMARY outcome

Timeframe: 4 weeks

Corneal coverage is collected on a YES/NO response. Yes - lens covers the cornea, No - lens does not cover the cornea

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Percentage of Participants With Corneal Coverage Assessment by the Investigator - Fanfilcon A Contact Lenses
Yes
100 percentage of participants
Percentage of Participants With Corneal Coverage Assessment by the Investigator - Fanfilcon A Contact Lenses
No
0 percentage of participants

PRIMARY outcome

Timeframe: Baseline

Post-blink movement, was rated at each visit using a 0-4 scale (0=Insufficient, unacceptable movement, 1=Minimal, but acceptable movement, 2=Optimal movement, 3=Moderate, but acceptable movement, 4=Excessive, unacceptable movement).

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Post-blink Movement Assessment by the Investigator - Methafilcon A Contact Lenses
1.90 units on a scale
Standard Deviation 0.3

PRIMARY outcome

Timeframe: 4 weeks

Post-blink movement, was rated at each visit using a 0-4 scale (0=Insufficient, unacceptable movement, 1=Minimal, but acceptable movement, 2=Optimal movement, 3=Moderate, but acceptable movement, 4=Excessive, unacceptable movement).

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Post-blink Movement Assessment by the Investigator - Methafilcon A Contact Lenses
1.95 units on a scale
Standard Deviation 0.3

PRIMARY outcome

Timeframe: Baseline

Post-blink movement, was rated at each visit using a 0-4 scale (0=Insufficient, unacceptable movement, 1=Minimal, but acceptable movement, 2=Optimal movement, 3=Moderate, but acceptable movement, 4=Excessive, unacceptable movement).

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Post-blink Movement Assessment by the Investigator - Fanfilcon A Contact Lenses
1.97 units on a scale
Standard Deviation 0.2

PRIMARY outcome

Timeframe: 2 weeks

Post-blink movement, was rated at each visit using a 0-4 scale (0=Insufficient, unacceptable movement, 1=Minimal, but acceptable movement, 2=Optimal movement, 3=Moderate, but acceptable movement, 4=Excessive, unacceptable movement).

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Post-blink Movement Assessment by the Investigator - Fanfilcon A Contact Lenses
1.97 units on a scale
Standard Deviation 0.2

PRIMARY outcome

Timeframe: 4 weeks

Post-blink movement, was rated at each visit using a 0-4 scale (0=Insufficient, unacceptable movement, 1=Minimal, but acceptable movement, 2=Optimal movement, 3=Moderate, but acceptable movement, 4=Excessive, unacceptable movement).

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Post-blink Movement Assessment by the Investigator - Fanfilcon A Contact Lenses
2.0 units on a scale
Standard Deviation 0.2

PRIMARY outcome

Timeframe: Baseline

Lens tightness was assessed using the push-up test and a 0 - 100% continuous scale (where 0% =falls from cornea without lid support, 50% = optimum and 100%=no movement).

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Lens Tightness Assessment by the Investigator - Methafilcon A Contact Lenses
53.59 units on a scale
Standard Deviation 9.6

PRIMARY outcome

Timeframe: 4 weeks

Lens tightness was assessed using the push-up test and a 0 - 100% continuous scale (where 0% =falls from cornea without lid support, 50% = optimum and 100%=no movement).

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Lens Tightness Assessment by the Investigator - Methafilcon A Contact Lenses
52.31 units on a scale
Standard Deviation 6.5

PRIMARY outcome

Timeframe: Baseline

Lens tightness was assessed using the push-up test and a 0 - 100% continuous scale (where 0% =falls from cornea without lid support, 50% = optimum and 100%=no movement).

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Lens Tightness Assessment by the Investigator - Fanfilcon A Contact Lenses
50.38 units on a scale
Standard Deviation 1.8

PRIMARY outcome

Timeframe: 2 weeks

Lens tightness was assessed using the push-up test and a 0 - 100% continuous scale (where 0% =falls from cornea without lid support, 50% = optimum and 100%=no movement).

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Lens Tightness Assessment by the Investigator - Fanfilcon A Contact Lenses
50.64 units on a scale
Standard Deviation 3.3

PRIMARY outcome

Timeframe: 4 weeks

Lens tightness was assessed using the push-up test and a 0 - 100% continuous scale (where 0% =falls from cornea without lid support, 50% = optimum and 100%=no movement).

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Lens Tightness Assessment by the Investigator - Fanfilcon A Contact Lenses
50.51 units on a scale
Standard Deviation 3.2

PRIMARY outcome

Timeframe: Baseline

Lens fit acceptance was evaluated using a 0 - 4 scale 0=Should not be worn, 1=Borderline but unacceptable, 2=Minimal acceptable, early review, 3=Not perfect but okay to dispense, 4=perfect

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Overall Lens Fit Acceptance by the Investigator - Methafilcon A Contact Lenses
3.69 units on a scale
Standard Deviation 0.6

PRIMARY outcome

Timeframe: 4 weeks

Lens fit acceptance was evaluated using a 0 - 4 scale 0=Should not be worn, 1=Borderline but unacceptable, 2=Minimal acceptable, early review, 3=Not perfect but okay to dispense, 4=perfect

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Overall Lens Fit Acceptance by the Investigator - Methafilcon A Contact Lenses
3.74 units on a scale
Standard Deviation 0.5

PRIMARY outcome

Timeframe: Baseline

Lens fit acceptance was evaluated using a 0 - 4 scale 0=Should not be worn, 1=Borderline but unacceptable, 2=Minimal acceptable, early review, 3=Not perfect but okay to dispense, 4=perfect

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Overall Lens Fit Acceptance by the Investigator - Fanfilcon A Contact Lenses
3.97 units on a scale
Standard Deviation 0.2

PRIMARY outcome

Timeframe: 2 weeks

Lens fit acceptance was evaluated using a 0 - 4 scale 0=Should not be worn, 1=Borderline but unacceptable, 2=Minimal acceptable, early review, 3=Not perfect but okay to dispense, 4=perfect

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Overall Lens Fit Acceptance by the Investigator - Fanfilcon A Contact Lenses
3.92 units on a scale
Standard Deviation 0.3

PRIMARY outcome

Timeframe: 4 weeks

Lens fit acceptance was evaluated using a 0 - 4 scale 0=Should not be worn, 1=Borderline but unacceptable, 2=Minimal acceptable, early review, 3=Not perfect but okay to dispense, 4=perfect

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Overall Lens Fit Acceptance by the Investigator - Fanfilcon A Contact Lenses
3.95 units on a scale
Standard Deviation 0.3

SECONDARY outcome

Timeframe: 4 weeks

Average daily wearing time response by the subject

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Average Daily Wearing Time - Methafilcon A Contact Lenses
12.1 hours / day
Standard Deviation 4.0

SECONDARY outcome

Timeframe: 2 weeks

Average daily wearing time response by the subject.

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Average Daily Wearing Time - Fanfilcon A Contact Lenses
12.2 hours / day
Standard Deviation 2.6

SECONDARY outcome

Timeframe: 4 weeks

Average daily wearing time response by the subject

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Average Daily Wearing Time - Fanfilcon A Contact Lenses
12.3 hours / day
Standard Deviation 2.6

SECONDARY outcome

Timeframe: 4 weeks

Average comfortable wearing time - response by the subject

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Average Comfortable Wearing Time - Methafilcon A Contact Lenses
10.0 hours / day
Standard Deviation 3.2

SECONDARY outcome

Timeframe: 2 weeks

Average comfortable wearing time - response by the subject

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Average Comfortable Wearing Time - Fanfilcon A Contact Lenses
9.6 hours / day
Standard Deviation 3.0

SECONDARY outcome

Timeframe: 4 weeks

Average comfortable wearing time - response by the subject

Outcome measures

Outcome measures
Measure
Methalfilcon A Contact Lenses
n=39 Participants
All subjects will wear methafilcon A contact lenses for four (4) weeks of daily wear. methafilcon A contact lenses: Bilateral daily wear of methafilcon A contact lenses
Average Comfortable Wearing Time - Fanfilcon A Contact Lenses
9.7 hours / day
Standard Deviation 2.9

Adverse Events

Methafilcon A

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Fanfilcon A

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Jose A. Vega, O.D, MSc., FAAO

CooperVision. Inc

Phone: 9256213761

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place